Vipin M. Vashishtha Profile picture
Pediatrician, ‘rational’ vaccine thinker, Editor Covid Vaccines, TB on Vaccines & many others, Past-Convener IAP COI, Member-WHO-VSN https://t.co/eOvazlWmWg
33 subscribers
Apr 21 6 tweets 2 min read
Remember COVID toes?

➡️ A study has found that people with pandemic chilblains have an unusually strong immune response to SARS-CoV-2, driven by overactive plasmacytoid dendritic cells (pDCs) responding to TLR7 signals. 1/ Image Given the essential role of type I interferon in protective immunity against SARS2 & the association of chilblains with inherited type I interferonopathies, researchers hypothesized that excessive I-IFN responses to SARS2 might underlie the occurrence of chilblains 2/ Image
Apr 19 7 tweets 2 min read
Differential DNA methylation 7 months after SARS-CoV-2 infection

A NEW study detected associations between changes in DNA methylation in individuals who had even asymptomatic or mild SARS-CoV-2 infections as compared to their household controls after 7 moths of infection 1/ Image Aberrant DNA methylation patterns have been linked to various diseases, including cancer and metabolic disorders. 

These changes resembled patterns seen in autoimmune or inflammatory diseases, suggesting long-term epigenetic remodeling even in mild cases. 2/ Image
Apr 19 11 tweets 4 min read
New research reveals that calming the brain's immune cells may reduce Alzheimer's disease inflammation. The study highlights the importance of norepinephrine, which could lead to more targeted, early, and personalized treatments. 1/ Image Norepinephrine is a major signaling factor in the brain and affects almost every cell type. In the context of neurodegenerative diseases such as Alzheimer's disease, it has been shown to be anti-inflammatory. 2/ Image
Apr 17 10 tweets 4 min read
#Metformin- A wonder drug!

➡️ A NEW study finds Metformin could prevent a form of acute myeloid leukemia (AML) in people at high risk of the disease.
Researchers investigated how metformin could prevent abnormal blood stem cells w/ genetic changes from progressing to AML 1/ Image Metformin impacts mitochondrial metabolism, & these pre-cancerous cells need this energy to keep growing. By blocking this process, researchers stop the cells from expanding & progressing towards AML, whilst also reversing other effects of mutated DNMT3A gene 2/ Image
Apr 16 12 tweets 4 min read
Does SARS-CoV-2 Possess “Allergen-Like” Epitopes?

It has been reported that repeated administration of some COVID vaccines induces high IgG4 levels.

New research revealed a surprising IgE anti-RBD response after both natural infection & several SARS-CoV-2 vaccines. 1/ Image Presence of IgG4 & IgE in COVID-19 suggests that the virus may induce an “allergic-like” response to evade immune surveillance, leading to a shift from Th1 to Th2 cells, which promotes tolerance to the virus & potentially contributes to chronic infection & may be LongCovid 2/ Image
Apr 15 12 tweets 4 min read
Cells are swapping their mitochondria. What does this mean for our health?

Researchers are studying why Mitochondria, the energy factories are moving between cells and whether the process can be harnessed to treat cancer and other diseases. 1/. Image It turns out that mitochondria can actually be transferred to other cells if needed.

Mitochondria move between different cells in 3 ways-through nanotubes, in extracellular bubble-shaped vesicles, or by free floating through the blood. 2/ Image
Apr 12 5 tweets 2 min read
SARS-CoV-2 has been widely reported to cause retinal pathological changes and to infect the embryonic retina. The infection of host cells by SARS-CoV-2 is primarily mediated through spike (S) protein, which also plays a crucial role in the pathogenesis of SARS-CoV-2. 1/ Image Spike protein exposure was studied in human embryonic stem cell-derived retinal organoids (hEROs) at various stages of retinal development. Immunofluorescence, RNA sequencing, and RT-PCR were used to determine how S protein exposure affects retinal development early and late 2/ Image
Apr 11 12 tweets 4 min read
Researchers have identified a new set of genes that contribute to the risk of Parkinson's disease (PD), which opens the door to previously untapped drug targets for treating PD.

PD is the 2nd most common neurodegenerative disease after Alzheimer's disease. 1/ Image A longstanding mystery in PD has been why some people carrying pathogenic variants that increase their risk of PD go on to develop the disease, while others who also carry such variants do not. The prevailing theory has suggested additional genetic factors may play a role 2/ Image
Apr 11 6 tweets 2 min read
A new study finds certain bacteria living in nose (nasal microbiome) may influence how likely someone is to get a COVID-19 infection. These bacteria can change crucial proteins the virus needs to enter human cells, explaining why some people are more susceptible to COVID 1/ Image Post-infection ACE2 and TMPRSS2 expression in the upper respiratory tract has been linked to increased disease severity among adults, and higher post-infection ACE2 expression has been linked to increased secondary transmission among adults,and risk of infection in children. 2/ Image
Apr 9 10 tweets 3 min read
Tackling the 'silent pandemic': Study puts first #LongCOVID treatment on horizon!

Researchers have shown a new drug compound can prevent long COVID symptoms in mice—a landmark finding that could lead to a future treatment for the debilitating condition 1/ Image The world-first study found mice treated with the antiviral compound, developed by a multidisciplinary research team at WEHI, institute were protected from long-term brain and lung dysfunction—key symptoms of long COVID. 2/ Image
Apr 8 7 tweets 3 min read
A potent Covid-19 vaccine in the making!

The RBD of the SARS-CoV-2 spike protein often mutates to help it evade immunity.

➡️ A modified COVID vaccine (SΔRBD) lacking the spike’s RBD showed strong lung protection, even better than mRNA vaccine in macaques. 1/ Image In order to steer the immune response away from RBD epitopes to more conserved domains, researchers generated S glycoprotein trimers without RBD and stabilized them by formaldehyde cross-linking. 2/ Image
Apr 7 5 tweets 2 min read
A man who had recovered from COVID and tested negative on nasopharyngeal swab was found to have SARS-CoV-2 spike protein in his small intestine, especially in ulcerated areas. 1/ Image This was associated with increased Vascular Endothelial Growth Factor (VEGF) and Fibronectin expression, as well as structural changes in intercellular junctions between intestinal cells. 2/ Image
Apr 7 8 tweets 3 min read
A NEW nasal spray H5N1 vaccine!

Researchers have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. 1/ Image Genetic surveillance has identified mutations that enhance H5N1's affinity for human upper respiratory cells, raising concerns that further adaptation or recombination with seasonal flu could significantly increase the risk of a pandemic. 2/ Image
Apr 3 9 tweets 3 min read
Researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment. 1/ Image As with its predecessor, the new drug candidate, Jun13296, targets a different viral protein than Paxlovid does and works alone rather than in combination with another drug called ritonavir. 2/ Image
Apr 2 8 tweets 3 min read
Even after 5 yrs since its arrival, SARS-CoV-2 mutations keep emerging. A new variant LP.8.1 is rising. Almost 1 in 5 COVID cases in New South Wales are it. In the UK, it accounts for at least 3 in 5 cases. Just what is LP.8.1? Is it worrying? 1/ Image LP.8.1 was first detected in July 2024. It’s a descendant of Omicron, specifically of KP.1.1.3, which is descended from JN.1, a subvariant that caused large waves of COVID infections around the world in late 2023 and early 2024. 2/ Image
Apr 1 17 tweets 5 min read
SARS-CoV-2 spike protein binds fibrinogen, causing thrombo-inflammation, according to a recent study. The virus must bind to fibrinogen, but why? Could this relationship help the virus evolve? Could this cause post-COVID heart attacks? 1/ Image Scientists often think they grasp a virus's anatomy, tricks, and body movement. But occasionally, we discover something unexpected that radically transforms how we view an infection. 2/ Image
Mar 27 10 tweets 4 min read
COVID-19 increases the risk of autoimmune diseases including rheumatoid arthritis and type 1 diabetes. The virus alters the immune system in unknown ways, making it difficult to design medicines to prevent post-COVID autoimmunity. 1/ Image One leading hypothesis involves viral “molecular mimics”—proteins from the virus that resemble the body’s own proteins. These mimics may trigger an immune response against the virus but unintentionally cause the immune system to target healthy tissues as well. 2/ Image
Mar 27 12 tweets 4 min read
mRNA-COVID-19 vaccines train the 'long-term memory' of immune system

Researchers have determined that the novel mRNA-COVID-19 vaccines not only induce acquired immune responses such as antibody production, but also cause persistent epigenetic changes in innate immune cells 1/ Image Thus, vaccination with mRNA vaccines could lead to an enhanced immune response to future encounters with pathogens which are not specifically targeted by the vaccine. 2/ Image
Mar 26 6 tweets 2 min read
In a proof-of-concept study, people with cognitive impairment in #LongCOVID were found to have asymmetrical glymphatic dysfunction in the left hemisphere of the brain which also correlated with disruption of the blood-brain barrier (BBB). 1/ Image A group of researchers used special MRI techniques to assess perivascular spaces in the brain of 14 individuals with LongCOVID compared to 10 healthy controls. 2/ Image
Mar 25 10 tweets 4 min read
Sugar coatings aren't only for candies; they also help viruses, like the ones that cause COVID-19, hide from their hosts' immune system.

Now, researchers have developed a universal vaccine that targets coronaviruses and the sugars that they use as cover. 1/ Image As demonstrated in animal studies, the vaccine removed sugar molecules from an area of a coronavirus spike protein that rarely mutates and created effective and plentiful antibodies to inactivate the virus. 2/ Image
Mar 25 8 tweets 3 min read
A NEW study found an increase in both the prevalence and severity of refractive astigmatism and corneal astigmatism after the COVID-19 pandemic. Corneal changes especially along the steepest meridian may explain some of the progression of corneal astigmatism. 1/ Image During the COVID-19 pandemic, school closures and lockdowns kept children indoors at unprecedented levels. Learning, play, and communication shifted almost entirely to digital screens. 2/